Cholangiopathy as part of post-COVID syndrome.
J Transl Autoimmun
; 4: 100116, 2021.
Article
in English
| MEDLINE | ID: covidwho-1392436
ABSTRACT
Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Language:
English
Journal:
J Transl Autoimmun
Year:
2021
Document Type:
Article
Affiliation country:
J.jtauto.2021.100116
Similar
MEDLINE
...
LILACS
LIS